Literature DB >> 22080976

Antioxidant therapies in traumatic brain and spinal cord injury.

Mona Bains1, Edward D Hall.   

Abstract

Free radical formation and oxidative damage have been extensively investigated and validated as important contributors to the pathophysiology of acute central nervous system injury. The generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) is an early event following injury occurring within minutes of mechanical impact. A key component in this event is peroxynitrite-induced lipid peroxidation. As discussed in this review, peroxynitrite formation and lipid peroxidation irreversibly damages neuronal membrane lipids and protein function, which results in subsequent disruptions in ion homeostasis, glutamate-mediated excitotoxicity, mitochondrial respiratory failure and microvascular damage. Antioxidant approaches include the inhibition and/or scavenging of superoxide, peroxynitrite, or carbonyl compounds, the inhibition of lipid peroxidation and the targeting of the endogenous antioxidant defense system. This review covers the preclinical and clinical literature supporting the role of ROS and RNS and their derived oxygen free radicals in the secondary injury response following acute traumatic brain injury (TBI) and spinal cord injury (SCI) and reviews the past and current trends in the development of antioxidant therapeutic strategies. Combinatorial treatment with the suggested mechanistically complementary antioxidants will also be discussed as a promising neuroprotective approach in TBI and SCI therapeutic research. This article is part of a Special Issue entitled: Antioxidants and antioxidant treatment in disease. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080976      PMCID: PMC4134010          DOI: 10.1016/j.bbadis.2011.10.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  132 in total

Review 1.  High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective.

Authors:  D J Short; W S El Masry; P W Jones
Journal:  Spinal Cord       Date:  2000-05       Impact factor: 2.772

2.  4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) inhibits peroxynitrite-mediated phenol nitration.

Authors:  R T Carroll; P Galatsis; S Borosky; K K Kopec; V Kumar; J S Althaus; E D Hall
Journal:  Chem Res Toxicol       Date:  2000-04       Impact factor: 3.739

3.  Temporal profiles and cellular sources of three nitric oxide synthase isoforms in the brain after experimental contusion.

Authors:  C Gahm; S Holmin; T Mathiesen
Journal:  Neurosurgery       Date:  2000-01       Impact factor: 4.654

4.  Traumatic injury to rat brain upregulates neuronal nitric oxide synthase expression and L-[3H]nitroarginine binding.

Authors:  V L Rao; A Dogan; K K Bowen; R J Dempsey
Journal:  J Neurotrauma       Date:  1999-10       Impact factor: 5.269

5.  Transcription factor Nrf2 protects the spinal cord from inflammation produced by spinal cord injury.

Authors:  Lei Mao; Handong Wang; Xiaoliang Wang; Hong Liao; Xianzhong Zhao
Journal:  J Surg Res       Date:  2011-06-23       Impact factor: 2.192

6.  Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.

Authors:  M B Bracken; M J Shepard; T R Holford; L Leo-Summers; E F Aldrich; M Fazl; M Fehlings; D L Herr; P W Hitchon; L F Marshall; R P Nockels; V Pascale; P L Perot; J Piepmeier; V K Sonntag; F Wagner; J E Wilberger; H R Winn; W Young
Journal:  JAMA       Date:  1997-05-28       Impact factor: 56.272

7.  Peroxynitrite scavengers for the acute treatment of traumatic brain injury.

Authors:  E D Hall; N C Kupina; J S Althaus
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

Review 8.  Melatonin in relation to cellular antioxidative defense mechanisms.

Authors:  R J Reiter; R C Carneiro; C S Oh
Journal:  Horm Metab Res       Date:  1997-08       Impact factor: 2.936

9.  Protective effect of tert-butylhydroquinone on cerebral inflammatory response following traumatic brain injury in mice.

Authors:  Wei Jin; Jie Kong; Handong Wang; Jun Wu; Tianyu Lu; Jian Jiang; Hongbin Ni; Weibang Liang
Journal:  Injury       Date:  2011-04-03       Impact factor: 2.586

10.  Potent protective effects of melatonin on experimental spinal cord injury.

Authors:  T Fujimoto; T Nakamura; T Ikeda; K Takagi
Journal:  Spine (Phila Pa 1976)       Date:  2000-04-01       Impact factor: 3.468

View more
  147 in total

1.  Cerebroprotection of flavanol (-)-epicatechin after traumatic brain injury via Nrf2-dependent and -independent pathways.

Authors:  Tian Cheng; Wenzhu Wang; Qian Li; Xiaoning Han; Jing Xing; Cunfang Qi; Xi Lan; Jieru Wan; Alexa Potts; Fangxia Guan; Jian Wang
Journal:  Free Radic Biol Med       Date:  2015-12-25       Impact factor: 7.376

Review 2.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

Review 3.  Resveratrol neuroprotection in stroke and traumatic CNS injury.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2015-08-12       Impact factor: 3.921

Review 4.  Protective effects of phenelzine administration on synaptic and non-synaptic cortical mitochondrial function and lipid peroxidation-mediated oxidative damage following TBI in young adult male rats.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Jacqueline R Kulbe; Edward D Hall
Journal:  Exp Neurol       Date:  2020-04-20       Impact factor: 5.330

5.  Previous physical exercise alters the hepatic profile of oxidative-inflammatory status and limits the secondary brain damage induced by severe traumatic brain injury in rats.

Authors:  Mauro Robson Torres de Castro; Ana Paula de Oliveira Ferreira; Guilherme Lago Busanello; Luís Roberto Hart da Silva; Mauro Eduardo Porto da Silveira Junior; Fernando da Silva Fiorin; Gabriela Arrifano; Maria Elena Crespo-López; Rômulo Pillon Barcelos; María J Cuevas; Guilherme Bresciani; Javier González-Gallego; Michele Rechia Fighera; Luiz Fernando Freire Royes
Journal:  J Physiol       Date:  2017-07-30       Impact factor: 5.182

Review 6.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 7.  Animal models of traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Nat Rev Neurosci       Date:  2013-02       Impact factor: 34.870

8.  Phenelzine Protects Brain Mitochondrial Function In Vitro and In Vivo following Traumatic Brain Injury by Scavenging the Reactive Carbonyls 4-Hydroxynonenal and Acrolein Leading to Cortical Histological Neuroprotection.

Authors:  John E Cebak; Indrapal N Singh; Rachel L Hill; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

9.  Functional and Structural Improvement with a Catalytic Carbon Nano-Antioxidant in Experimental Traumatic Brain Injury Complicated by Hypotension and Resuscitation.

Authors:  Kimberly Mendoza; Paul J Derry; Leela Mathew Cherian; Robert Garcia; Lizanne Nilewski; J Clay Goodman; Lamin Mbye; Claudia S Robertson; James M Tour; Thomas A Kent
Journal:  J Neurotrauma       Date:  2019-03-13       Impact factor: 5.269

Review 10.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.